Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-002369
Filing Date
2025-01-10
Accepted
2025-01-10 11:05:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 30098
  Complete submission text file 0001104659-25-002369.txt   31802
Mailing Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105
Business Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105 314-726-6700
RiverVest Venture Fund III, L.P. (Filed by) CIK: 0001601559 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91764 | Film No.: 25521368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)